Newsfile Corp. is a press release service for companies of all sizes. With a distribution of over 6,000 media and financial databases, Newsfile delivers press releases to a global audience.
BUSINESS ACCOUNT
Sign up for a business account to:
-
Access reports individually or via Subscription
-
Receive monthly invoices with payment via CSA or hard dollars
Get access to other exclusive features
-
Analyst access
-
Free Trial Subscriptions
-
Team account with shared subscriptions
-
Advanced analytics to track research consumption and performance
Casa Minerals Inc. Announces Non-Brokered Private Placement Raising $8...
Vancouver, British Columbia--(Newsfile Corp. - January 14, 2026) - Casa Minerals Inc. (TSXV: CASA) (OTCQB: CASXF) (FSE: 0CM) (the "Company" or "Casa") is pleased to announce a non-brokered private placement financing (the "Offering") for aggregate gross proceeds of $800,000.Under the terms of the Offering, the Company may issue up to 6,400,000 units (each, a "Unit") at a price of $0.125 per Unit. Each Unit consists of one common share of the Company (a "Share") and one common share purchase warrant (a "Warrant"). Each Warrant entitles the holder to acquire one additional Share for a period of ...
Cosa Appoints Justin Rodko as VP Corporate Development and Issues Shar...
Vancouver, British Columbia--(Newsfile Corp. - January 14, 2026) - Cosa Resources Corp. (TSXV: COSA) (OTCQB: COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to report the promotion of Justin Rodko to Vice President, Corporate Development. Additionally, the Company announces the issuance of common shares to its largest shareholder and joint venture partner Denison Mines Corp. (TSX: DML) (NYSE American: DNN) ("Denison") pursuant to the acquisition agreement between Cosa and Denison dated November 26, 2024 (the "Acquisition Agreement").Mr. Rodko is a Professional Geoscientist with over a ...
OS Therapies Announces Filing Form S-1 of OS Animal Health Subsidiary
OS Animal Health (OSAH), a wholly-owned subsidiary of OS Therapies (OSTX), targeting Initial Public Offering (IPO) on NYSE American or Nasdaq Capital Markets national stock exchange in the first half of 2026 (1H/2026)OSTX shareholders expected to receive one (1) share of OSAH for every ten (10) shares of OSTX owned as of the expected to-be-determined 1H/2026 record dateOSAH to focus primarily on the re-establishment of USDA conditional approval and commercialization of immunotherapy OST-HER2 for canine osteosarcoma and other HER2 positive cancers in animalsOST-HER2 featured in 2025 2x Emmy-nom...
Thiogenesis Therapeutics' MELAS Abstract Accepted for Late-Breaking Ne...
San Diego, California--(Newsfile Corp. - January 13, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare mitochondrial and metabolic diseases, today announced that an abstract outlining preliminary results from its Phase 2 clinical trial of TTI-0102 for Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) in the EU has been accepted as Late-Breaking News for presentation at the Mitocon Conference 2026, which will take place...
Gorilla Technology Announces Three New Project Wins in Taiwan Across P...
London, United Kingdom--(Newsfile Corp. - January 13, 2026) - Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company"), a global solution provider in AI-driven Security Intelligence, Network Intelligence, Business Intelligence and IoT technology today announced it has secured three new project wins in Taiwan secured between 30th December 2025 and 5th January 2026. The awards extend Gorilla's active deployments across public safety critical infrastructure and environmental protection. These agreements will provide a meaningful contribution to revenue, but contract values will n...
